Extending the Use of Antivirals to Treat Influenza in Infants

Scientists from d3 Medicine—part of Certara’s Strategic Consulting division—helped Roche apply an integrated clinical pharmacology program to support the development and global approval of Tamiflu for infants.

Read this case study to learn how Certara tools helped the sponsor:

  • Evaluate PK/safety/virology in infants
  • Use modeling and simulation to inform dosing
  • Develop a global filing strategy
  • Optimize clinical studies

Web-CTA-CaseStudy

Learn More LinkedIn Twitter Facebook Email